Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Disease After Neoadjuvant Chemo or at High Risk After Primary Surgery and Adjuvant Chemo"
By
ecancer
FEATURING
Pierfranco Conte
By
ecancer
FEATURING
Pierfranco Conte
0 views
July 2, 2024
Comments 0
Login to view comments.
Click here to Login